SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-18-000868
Filing Date
2018-06-04
Accepted
2018-06-04 18:00:27
Documents
1
Period of Report
2018-05-29

Document Format Files

Seq Description Document Type Size
1 form3-06042018_030611.html 3  
1 form3-06042018_030611.xml 3 1635
  Complete submission text file 0001415889-18-000868.txt   3062
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Issuer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 25801 INDUSTRIAL BLVD SUITE B HAYWARD CA 94545
Business Address
Pennington James (Reporting) CIK: 0001668704 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37853 | Film No.: 18879402